326 related articles for article (PubMed ID: 15605761)
1. [Modern approaches to estrogen-independent growth of breast tumor].
Krasil'nikov MA
Vopr Onkol; 2004; 50(4):399-405. PubMed ID: 15605761
[No Abstract] [Full Text] [Related]
2. [Breast cancer].
Iwase H
Nihon Rinsho; 2006 Sep; Suppl 3():379-83. PubMed ID: 17022569
[No Abstract] [Full Text] [Related]
3. New approaches to reverse resistance to hormonal therapy in human breast cancer.
Weinberg OK; Marquez-Garban DC; Pietras RJ
Drug Resist Updat; 2005 Aug; 8(4):219-33. PubMed ID: 16054421
[TBL] [Abstract][Full Text] [Related]
4. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
5. [Breast neoplasms: predictive factors for endocrine therapy ].
Hayashi S
Nihon Rinsho; 2007 Jun; 65 Suppl 6():148-53. PubMed ID: 17682151
[No Abstract] [Full Text] [Related]
6. Mechanisms of tamoxifen resistance.
Ring A; Dowsett M
Endocr Relat Cancer; 2004 Dec; 11(4):643-58. PubMed ID: 15613444
[TBL] [Abstract][Full Text] [Related]
7. [Growth control of breast cancer in relation to hormones].
Tominaga T; Yoshida Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3685-90. PubMed ID: 2688558
[TBL] [Abstract][Full Text] [Related]
8. Sensing estrogen's many pathways.
Weatherman RV
ACS Chem Biol; 2008 Jun; 3(6):338-40. PubMed ID: 18570353
[TBL] [Abstract][Full Text] [Related]
9. [Response to tamoxifen in estrogen receptor-positive cell line MCF-7 is independent of p53 expression].
Shtam TA; Pantina RA; Varfolomeeva EIu; Filatov MV
Vopr Onkol; 2007; 53(2):194-9. PubMed ID: 17663174
[TBL] [Abstract][Full Text] [Related]
10. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
Jordan VC; O'Malley BW
J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
[TBL] [Abstract][Full Text] [Related]
12. [Adjuvant treatment of breast cancer. Endocrine therapy].
Mouridsen HT; Andersen J
Ugeskr Laeger; 2007 Sep; 169(37):3072-6. PubMed ID: 17877951
[TBL] [Abstract][Full Text] [Related]
13. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
14. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk.
Massarweh S; Schiff R
Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S15-24. PubMed ID: 17259554
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-receptor biology: continuing progress and therapeutic implications.
Osborne CK; Schiff R
J Clin Oncol; 2005 Mar; 23(8):1616-22. PubMed ID: 15755967
[No Abstract] [Full Text] [Related]
16. Membrane-initiated steroid signaling action of estrogen and breast cancer.
Song RX
Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen for early breast cancer.
Nurs Times; 2001 Jun 21-27; 97(25):41. PubMed ID: 11957988
[No Abstract] [Full Text] [Related]
18. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate.
Fernandez Gacio A; Fernandez-Marcos C; Swamy N; Dunn D; Ray R
J Cell Biochem; 2006 Oct; 99(3):665-70. PubMed ID: 16795032
[TBL] [Abstract][Full Text] [Related]
19. Hormones and breast cancer in vitro.
Dickson RB; Thompson EW; Lippman ME
Hum Cell; 1989 Sep; 2(3):219-30. PubMed ID: 2519209
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
Yu Y; Zhou Q; Hang Y; Bu X; Jia W
Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]